Cargando…
Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells
Post-transcriptional gene silencing is a promising therapy for the monogenic, autosomal dominant, Huntington’s disease (HD). However, wild-type huntingtin (HTT) has important cellular functions, so the ideal strategy would selectively lower mutant HTT while sparing wild-type. HD patients were genoty...
Autores principales: | Miller, James R. C., Pfister, Edith L., Liu, Wanzhao, Andre, Ralph, Träger, Ulrike, Kennington, Lori A., Lo, Kimberly, Dijkstra, Sipke, Macdonald, Douglas, Ostroff, Gary, Aronin, Neil, Tabrizi, Sarah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402279/ https://www.ncbi.nlm.nih.gov/pubmed/28436437 http://dx.doi.org/10.1038/srep46740 |
Ejemplares similares
-
Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington’s Disease T Lymphocytes
por: Miller, James R. C., et al.
Publicado: (2015) -
Safe and Efficient Silencing with a Pol II, but Not a Pol lII, Promoter Expressing an Artificial miRNA Targeting Human Huntingtin
por: Pfister, Edith L., et al.
Publicado: (2017) -
Wild-type huntingtin regulates human macrophage function
por: O’Regan, Grace C., et al.
Publicado: (2020) -
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
por: Monteys, Alex Mas, et al.
Publicado: (2017) -
A Fresh Look at Huntingtin mRNA Processing in Huntington’s Disease
por: Romo, Lindsay, et al.
Publicado: (2018)